ClinicalTrials.gg
Sign In
RecruitingNCT07299487ADPVUpdated Dec 23, 2025

Diagnostic Aid for Vertigo Patients

An observational study in Vertigo, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Sep 2024; still recruiting 2 years 2 months later.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

Consultations for vertigo in general practice are difficult, primarily due to practitioners' lack of experience. Patient referrals can be inaccurate, leading to missed opportunities or misuse of resources. The creation of a diagnostic aid flowchart that provides referrals will improve patient care and reassure general practitioners during consultations for vertigo.

02

Conditions studied

  • Vertigo

Browse trials for

Keywords

  • Vertigo
03

In context

Vertigo

187 studies on the registry are indexed under Vertigo; 27 are open to participants now.

This study's planned enrollment of 50 is below the median of 198 across 42 observational studies indexed under Vertigo.

Browse Vertigo studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Browse University Hospital, Strasbourg, France studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult subject having received initial care from a medical student and whose consultation data, interview, clinical examination, and diagnosis according to our decision tree were present in the patient file.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject of legal age (≥18 years)
  • Having received initial care from a medical student and whose consultation data, interview, clinical examination, and diagnosis according to our decision tree were present in the patient file.
  • Patient for whom a definitive diagnosis was made by the on-call ENT physician during the same hospital visit.

Exclusion criteria

Exclusion Criteria:

  • Subject who expressed objection to the reuse of their data for scientific research.
  • Known chronic vestibular pathology
  • Incomplete patient medical file
  • Patient examined outside the ENT department.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Percentage of concordance between the diagnosis in the decision tree and the diagnosis made by an ENT (otolaryngologist) physician.

    Time frame: Up to 1 year

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Dec 2025, 15 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Dec 23, 2025
StartActual
Sep 9, 2024
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Dec 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07299487
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Dec 23, 2025
Start date
Sep 9, 2024
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Dec 23, 2025

Study contacts

Guillaume TRAU, MD
Contact
guillaume.trau@chru-strasbourg.fr
33 3 88 12 76 44

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Vertigo →

Other studies from this sponsor

University Hospital, Strasbourg, France →

Start the discussion